United States ex rel. Kirk v. CareFusion et al.: A medical device maker has agreed to pay $40.1 million to various states and the federal government, including $77,000 to Connecticut, to resolve civil claims by the U.S. government that it used unlawful marketing tactics and kickbacks to promote its products.
San Diego, Cal.-based CareFusion allegedly promoted and marketed their surgical preparation solution called Chloraprep for uses that were not approved by the Food and Drug Administration and for uses that were not medically intended.
